文献速递生殖医学

同源与异源精浆外泌体对冻融人精子的保护作用

Seminal exosome protection of frozen human spermatozoa: homologous versus heterologous treatment.
PubMed 文献 · Reprod Biomed Online · 2025-12-27

该体外实验纳入50例正常精子和50例少弱畸精子症男性的精液,比较同源与异源精浆外泌体处理对冻融后精子质量的影响。同源处理改善少弱畸精子症精子的前向运动、DNA碎片率、总抗氧化能力和膜完整性;异源处理对正常精子有不利影响。

要点

  • 同源精浆外泌体可改善少弱畸精子症冻融后前向运动、DNA碎片率和膜完整性。
  • 正常精子经同源外泌体处理可改善运动力和DNA碎片率。
  • 异源(少弱畸来源)外泌体降低正常精子运动力和线粒体膜电位。

核心结论

  • 正常来源精浆外泌体对正常和少弱畸精子症精子的冻存结局均有改善作用。
  • 少弱畸来源外泌体对正常精子有不良影响,但对少弱畸精子症精子有保护作用。

研究设计与样本

  • 体外实验研究,纳入50例正常精子症男性和50例少弱畸精子症男性的精液样本。
  • 精液经外泌体分离后分为同源处理组、异源处理组和未处理对照组,冻存后评估精子质量。

主要发现

  • 少弱畸精子症精子同源处理组较未处理组前向运动改善(P=0.04)、DNA碎片率降低(P=0.014)、总抗氧化能力提高(P=0.0005)、膜完整性改善(P=0.04)。
  • 正常精子同源处理组较未处理组运动力改善(P=0.048)、DNA碎片率降低(P=0.015)。
  • 少弱畸精子症精子异源处理组较未处理组运动力提高(P=0.03)。
  • 正常精子异源处理组较未处理组运动力下降(P=0.002)、线粒体膜电位降低(P=0.03)。

临床怎么用

  • 精浆外泌体有望作为冷冻保护添加剂,优化精子冻存流程。
  • 同源外泌体处理可能优于传统去除精浆的做法,保留精浆环境关键成分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: How do homologous and heterologous seminal exosome treatments influence the quality of post-thaw spermatozoa? DESIGN: In this in-vitro experimental study, semen samples were collected from 50 normozoospermic (N) and 50 oligoasthenoteratozoospermic (OAT) men undergoing analysis at an academic infertility centre. After exosome isolation, samples were treated with either N-derived exosomes (n-EXO) or OAT-derived exosomes (o-EXO) or left untreated before cryopreservation. The groups were thus N-nEXO and O-oEXO (homologous), N-oEXO and O-nEXO (heterologous) and untreated N and O controls. Post-thaw sperm quality was evaluated using motility, sperm DNA fragmentation (SDF), total antioxidant capacity (TAC), total oxidative status, mitochondrial membrane potential (MMP), membrane integrity and apoptosis. RESULTS: Homologous treatment significantly improved OAT spermatozoa (O versus O-oEXO) in terms of progressive motility (P = 0.04), SDF (P = 0.014), TAC (P = 0.0005) and membrane integrity (P = 0.04). In N samples, n-EXO also improved motility (P = 0.048) and SDF (P = 0.015). Heterologous treatment increased motility in OAT spermatozoa (O versus O-nEXO, P = 0.03) but reduced motility (P = 0.002) and MMP (P = 0.03) in N spermatozoa (N versus N-oEXO). CONCLUSIONS: These findings support the beneficial role of n-EXO in enhancing cryopreservation outcomes for both N and OAT spermatozoa. Interestingly, o-EXO exerted adverse effects on N spermatozoa but demonstrated a protective effect on OAT spermatozoa, contrary to initial expectations. The observed improvements with homologous treatments highlight the potential of using seminal exosomes as an alternative approach to the traditional removal of seminal plasma, reinforcing the importance of preserving key components of the seminal environment during freezing. Consequently, seminal exosomes could potentially serve as cryoprotectant additives to optimize sperm cryopreservation procedures.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Rezayi S, Sadighi Gilani MA, Naji M, et al. Seminal exosome protection of frozen human spermatozoa: homologous versus heterologous treatment. Reprod Biomed Online. 2025. PMID: 42607600. doi:10.1016/j.rbmo.2025.105445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。